Has Nomita Kim, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,345,591 in general payments to Nomita Kim, MD across 699 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nomita Kim, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nomita Kim, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nomita Kim, MD

Family Medicine · Austin, TXNPI 1013070754

Payments from drug & device makers

$3,345,591in general payments, 2019–2025

Across 699 payments — averaging $4786.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eli Lilly$1.4M
Modernatx, Inc.$1.1M
Boehringer Ingelheim International GmbH$329K
Bristol Myers Squibb$100K
Amgen$85K
AstraZeneca$69K
plus $276K from 42 others

$32,336in research payments, 2019–2025

Across 3 payments — averaging $10,779 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$32K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eli Lilly	50	$1,385,482
Modernatx, Inc.	73	$1,100,592
Boehringer Ingelheim International GmbH	260	$329,380
Bristol Myers Squibb	4	$99,684
Amgen	23	$85,201
AstraZeneca	8	$68,949
Regeneron	18	$67,107
AbbVie(2 entities)	59	$64,089
Pfizer	16	$39,464
Siemens Medical Solutions USA, Inc.	7	$23,380
GSK	21	$19,598
Otsuka Pharmaceutical Development & Commercialization, Inc.	2	$18,566
Adare Pharmaceuticals, Inc.	7	$15,748
Janssen Research & Development, LLC	2	$9,435
Hikma Pharmaceuticals USA	2	$8,705
Novartis	2	$7,045
Lilly USA, LLC	49	$775
Abbott	24	$543
Esperion Therapeutics, Inc.	7	$214
Boehringer Ingelheim	8	$208
Axsome Therapeutics, Inc.	4	$175
Novo Nordisk	8	$150
Biogen	2	$118
Merck	4	$118
Vifor Pharma, Inc.	1	$115
Takeda Pharmaceuticals U.S.A., Inc.	6	$110
Impulse Dynamics (USA) Inc.	1	$80
Convatec Inc.	2	$51
Kowa Pharmaceuticals America, Inc.	3	$47
Bayer	2	$46
Dexcom, Inc.	2	$39
Medtronic	2	$36
Amarin Pharma, Inc.	2	$35
Corcept Therapeutics	2	$33
Astellas Pharma US Inc	2	$32
Teva Pharmaceuticals USA, Inc.	2	$26
Bausch Health US, LLC	1	$24
Romark Laboratories, LC	1	$24
Sumitomo Pharma America, Inc.	1	$22
Mayne Pharma Commercial LLC	1	$21
Otsuka America Pharmaceutical, Inc.	1	$19
Hologic Sales And Service, LLC	1	$18
Aytu Biopharma, Inc.	1	$17
Paratek Pharmaceuticals, Inc.	1	$17
Gilead	1	$16
Xeris Pharmaceuticals, Inc.	1	$15
Ironshore Pharmaceuticals Inc.	1	$12
Circassia Inc.	1	$11

How this compares

$3,345,591 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas →

Medicare billing

Part B allowed, 2024

$159,611

Medicare patients

150

Services billed

3,382

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Austin

Cynthia BrinsonAustin$13.9M
Gregg LucksingerAustin$11.4M
Faith HolmesAustin$7.5M
Gretchen CrookAustin$4.4M
Matthew BrimberryAustin$3.8M
Douglas DenhamSan Antonio$68.5M
Vicki MillerPasadena$58.3M
Hareshkumar BogharaDesoto$30.3M
Earl MartinTomball$30.1M
Lisa HollowayHouston$30.1M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →